From 3D Culture to Clinical Decision-Making: Systematic Innovations in Breast Cancer Organoids

The authors integrate cutting-edge technologies such as organ-on-a-chip and CRISPR/Cas9 gene editing to summarize the multidimensional generation strategy of breast cancer organoids and discuss the clinical value of translation from diagnosis to therapy.